Trial intelligence / Profile preview

Early Treatment of Recurrent HCV Post Liver Transplant

NCT03133065Phase 4Completed

Sponsor
Ain Shams University
Start
Sep 2014
Primary completion
Dec 2016
Modality
Small Molecules
01

Overview

A Phase 4 trial of daclatasvir in hepatitis C (HCV), sponsored by Ain Shams University. Started Sep 2014; status: completed.

02

Drugs

daclatasvir
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT03133065.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03133065.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call